Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Gary R. Lichtenstein, MD
Professor of Medicine
Director, Center for Inflammatory Bowel Diseases
The Raymond and Ruth Perelman School of Medicine of the University of Pennsylvania
Hospital of the University of Pennsylvania
Gastroenterology Division, Department of Internal Medicine
Perelman Center for Advanced Medicine
Consulting: Abbvie, Actavis, Alaven, CellCeutrix, Celgene, Ferring, Gilead, Hospira, Janssen Biotech, Luitpold/American Regent, Pfizer Pharmaceuticals, Prometheus Laboratories, Inc., Romark, Salix Pharmaceuticals/Valeant, Santarus/Receptos/Celgene, Shire Pharmaceuticals, Takeda, UCB
Contracted Research: Celgene, Janssen Biotech, Salix Pharmaceuticals/Valeant, Santarus/Receptos/Celgene, Shire Pharmaceuticals, UCB
Other (Honorarium): Clinical Advances in Gastroenterology (Editor), Gastro-Hep Communications (Editor), Ironwood (CME Program), Luitpold/American Regent (CME Program), Merck (CME Program), McMahon Publishing (Author), Romark (CME), Springer Science and Business Media (Editor), Up-To-Date (Author)
Funding to University of Pennsylvania: Janssen Biotech (IBD Fellow Education), Pfizer Pharmaceuticals (IBD Fellow Education), Takeda (IBD Fellow Education)
Royalty: SLACK, Inc. (Book Royalty)
Michael Cirigliano, MD, FACP
Founder's Associate Professor of General Internal Medicine
Perelman School of Medicine at the
University of Pennsylvania
Fees for Non-CME/CE Services Received Directly from a Commercial Supporter: Medical Contributor, Fox29 News
The PIM planners and managers have nothing to disclose. The peerXchange planners and managers have nothing to disclose.
Method of Participation
There are no fees to participate in the enduring activity. During the period July 31, 2018 through July 31, 2019, participants must 1) read the CME information, including learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the pre-test, post-test and evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, submit and your post-test will automatically be graded. Once you successfully complete the post-test (score of 70% or greater) and activity evaluation, your Statement of Credit will be made available immediately to view or print for your records.
© 2018. This CME-certified activity is held as copyrighted © by peerXchange. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).